Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients

Abstract

Treatment with a high-dose folic acid, B6, and B12 multivitamin in kidney transplant recipients did not reduce a composite cardiovascular disease outcome, all-cause mortality, or dialysis-dependent kidney failure despite significant reduction in homocysteine level.